Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Atrial Fibrillation in Patients With High Sympathetic Activity by Pulmonary Vein Isolation in Combination With Renal Denervation or Pulmonary Vein Isolation Only; an International Randomized, Controlled Trial

NCT02115100 is registered in ClinicalTrials.gov with Diagram B.V. as lead sponsor.

NCT NCT02115100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02115100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Atrial Fibrillation in Patients With High Sympathetic Activity by Pulmonary Vein Isolation in Combination With Renal Denervation or Pulmonary Vein Isolation Only; an International Randomized, Controlled Trial
Lead sponsor
Diagram B.V.
Phase
Not applicable
Overall status
Completed
Start date
March 18, 2014
Completion date
January 19, 2022
Enrollment
145 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

out of range hypertension, paroxysmal atrial fibrillation, persistent atrial fibrillation, signs of sympathetic overdrive